SG11202109160UA - Reducing intersample analyte variability in complex biological matrices - Google Patents
Reducing intersample analyte variability in complex biological matricesInfo
- Publication number
- SG11202109160UA SG11202109160UA SG11202109160UA SG11202109160UA SG 11202109160U A SG11202109160U A SG 11202109160UA SG 11202109160U A SG11202109160U A SG 11202109160UA SG 11202109160U A SG11202109160U A SG 11202109160UA
- Authority
- SG
- Singapore
- Prior art keywords
- intersample
- reducing
- complex biological
- biological matrices
- analyte variability
- Prior art date
Links
- 239000012491 analyte Substances 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6827—Total protein determination, e.g. albumin in urine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/34—Purifying; Cleaning
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/493—Physical analysis of biological material of liquid biological material urine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/06—Investigating concentration of particle suspensions
- G01N15/075—Investigating concentration of particle suspensions by optical means
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N2030/022—Column chromatography characterised by the kind of separation mechanism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Ecology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962822349P | 2019-03-22 | 2019-03-22 | |
PCT/US2020/023866 WO2020198011A1 (en) | 2019-03-22 | 2020-03-20 | Reducing intersample analyte variability in complex biological matrices |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202109160UA true SG11202109160UA (en) | 2021-10-28 |
Family
ID=70228886
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202109160U SG11202109160UA (en) | 2019-03-22 | 2020-03-20 | Reducing intersample analyte variability in complex biological matrices |
Country Status (10)
Country | Link |
---|---|
US (1) | US20220178940A1 (de) |
EP (1) | EP3942295A1 (de) |
JP (1) | JP2022524975A (de) |
KR (1) | KR20210142694A (de) |
CN (1) | CN113508297A (de) |
AU (1) | AU2020245346A1 (de) |
CA (1) | CA3134336A1 (de) |
IL (1) | IL286495A (de) |
SG (1) | SG11202109160UA (de) |
WO (1) | WO2020198011A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4233088A4 (de) * | 2020-10-20 | 2024-10-02 | Definitek Inc | Quantifizierung von zuvor nicht nachweisbaren mengen |
CN112666356A (zh) * | 2020-12-31 | 2021-04-16 | 国家纳米科学中心 | 一种检测痕量蛋白质的方法 |
CN116899626B (zh) * | 2023-09-08 | 2023-12-26 | 北京青颜博识健康管理有限公司 | 一种点击化学反应的催化体系组合物及其制备方法和在生物检测中的应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE318832T1 (de) | 1990-06-11 | 2006-03-15 | Gilead Sciences Inc | Verfahren zur vervendung von nukleinsäureliganden |
US5719273A (en) | 1993-06-14 | 1998-02-17 | Nexstar Pharmaceuticals, Inc. | Palladium catalyzed nucleoside modifications methods using nucleophiles and carbon monoxide |
US5945527A (en) | 1996-05-30 | 1999-08-31 | Nexstar Pharmaceuticals, Inc. | Palladium catalyzed nucleoside modification methods using nucleophiles and carbon monoxide |
US6242246B1 (en) | 1997-12-15 | 2001-06-05 | Somalogic, Inc. | Nucleic acid ligand diagnostic Biochip |
US7855054B2 (en) | 2007-01-16 | 2010-12-21 | Somalogic, Inc. | Multiplexed analyses of test samples |
US7947447B2 (en) | 2007-01-16 | 2011-05-24 | Somalogic, Inc. | Method for generating aptamers with improved off-rates |
US20100254581A1 (en) * | 2009-04-07 | 2010-10-07 | Reveal Sciences, Llc | Device, method, and apparatus for biological testing with a mobile device |
EP2558478B1 (de) | 2010-04-12 | 2018-03-07 | Somalogic, Inc. | An 5 positionen modifizierte pyrimidine und ihre verwendung |
-
2020
- 2020-03-20 EP EP20718109.0A patent/EP3942295A1/de active Pending
- 2020-03-20 SG SG11202109160U patent/SG11202109160UA/en unknown
- 2020-03-20 US US17/438,120 patent/US20220178940A1/en active Pending
- 2020-03-20 CN CN202080018439.0A patent/CN113508297A/zh active Pending
- 2020-03-20 KR KR1020217033765A patent/KR20210142694A/ko unknown
- 2020-03-20 JP JP2021552175A patent/JP2022524975A/ja active Pending
- 2020-03-20 AU AU2020245346A patent/AU2020245346A1/en active Pending
- 2020-03-20 CA CA3134336A patent/CA3134336A1/en active Pending
- 2020-03-20 WO PCT/US2020/023866 patent/WO2020198011A1/en active Application Filing
-
2021
- 2021-09-19 IL IL286495A patent/IL286495A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA3134336A1 (en) | 2020-10-01 |
AU2020245346A1 (en) | 2021-09-09 |
IL286495A (en) | 2021-10-31 |
US20220178940A1 (en) | 2022-06-09 |
KR20210142694A (ko) | 2021-11-25 |
CN113508297A (zh) | 2021-10-15 |
WO2020198011A1 (en) | 2020-10-01 |
JP2022524975A (ja) | 2022-05-11 |
EP3942295A1 (de) | 2022-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL286495A (en) | Reducing inter-sample analysis variability in complex biological matrices | |
EP3371194A4 (de) | Proteinsequenzierungsverfahren und reagenzien | |
SG11202105441WA (en) | Direct oligonucleotide synthesis on cells and biomolecules | |
IL290245A (en) | Single cell analysis | |
EP3735481A4 (de) | Verfahren zur herstellung eines hochauflösenden dna-arrays und seine anwendung in der sequenzierung | |
IL288014A (en) | Controlling inter-sample test substance variability in complex biological matrices | |
HK1254396A1 (zh) | 一種dna片段體外組裝方法和試劑盒 | |
IL279921A (en) | A system and method of evaluating and determining color in gemstones | |
GB201813449D0 (en) | Skin cell analysis | |
EP3815094A4 (de) | Nukleinsäureumordnung und integrationsanalyse | |
EP3880151A4 (de) | Bestimmung der behandlungsreaktion in einzelnen zellen | |
IL261835A (en) | Analytical methods and arrays for their use | |
GB201913908D0 (en) | Improvements in interaction analysis | |
SG11202108157WA (en) | Biological analysis system and methods | |
SG11202102265UA (en) | Hemoglobin assay reagent, assay kit and assay method | |
IL281796A (en) | Quantification of antibody in biological samples | |
SG11202110398QA (en) | Concurrent analysis of multiple analytes | |
EP3891301A4 (de) | Quantifizierung von fremd-dna in blutproben mit niedrigem volumen mittels snp-profilierung | |
EP3610012A4 (de) | Hochdurchsatz-absorptionsmessungen von proben in mikrokapillaranordnungen | |
IL278937A (en) | HSP70 protein levels in PBMC samples as a disease biomarker | |
EP3814500A4 (de) | Verfahren zur analyse von dna in urin | |
GB201710524D0 (en) | Controlling intersample analyte variability in complex biological matrices | |
IL287077A (en) | Methods and systems for scanning using a microcapillary array | |
IL286419A (en) | A cell line containing a new form of selection marker and using them to make proteins | |
GB201918900D0 (en) | Improvements in or relating to assay timing |